-
For postmenopausal women with estrogen-receptor-positive breast cancer who are receiving hormone therapy and who are overweight or obese, the risk for disease recurrence is significantly lower if they also take nonsteroidal anti-inflammatory drug (NSAIDs), such as aspirin, on a daily […]
read more -
ZURICH (Reuters) – A new drug from Roche for women with an incurable form of breast cancer is too expensive for routine use on Britain’s state-run health service even after a discount, the country’s healthcare cost watchdog ruled on Friday. […]
read more -
There is now evidence that mutations in the PALB2 gene are associated with a significantly increased risk for breast cancer in women. In fact, the risk of developing breast cancer at the age of 70 is 35% higher in women […]
read more -
A link has been found between high blood cholesterol and breast cancer risk in a large retrospective cross-sectional study, according to research presented at Frontiers in CardioVascular Biology 2014 in Barcelona, Spain. However, the lead investigator cautioned that this […]
read more -
UPDATED // A biomedical researcher with an unusually virulent form of breast cancer has taken an extraordinary step to “immortalize” her cancer cells. Kimberly L. Koss, PhD, 57, skipped standard preoperative chemotherapy in an effort to culture pure versions […]
read more -
CHICAGO — Relapse after the treatment of primary breast cancer can be reliably predicted well in advance of clinical indications with a circulating free DNA (cfDNA) test, according to a new study. Results were presented here at the 2014 […]
read more -
The “brain fog” many patients experience after chemotherapy might be related to chemotherapy-induced damage to the brain or reduced connectivity between brain regions, according to new research. In a prospective longitudinal study, women with breast cancer who received chemotherapy […]
read more -
In their advertisements to the general public, cancer centers in the US use emotional appeals that evoke hope and fear, and rarely provide information about risks, benefits, costs, or insurance, a new study has found. The approach may lead to […]
read more -
NEW YORK (Reuters Health) – Breast cancer subtypes vary by ethnicity across socioeconomic status (SES) strata, according to results from the National Cancer Data Base (NCDB). “Minority women are more likely to be diagnosed with the least favorable prognosis […]
read more -
Obesity increases the risk of dying from breast cancer by a third, a huge new study shows. However, the effect of obesity was only observed in premenopausal women with estrogen-receptor (ER)-positive disease. Surprisingly, obesity seemed to have little effect […]
read more
